{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["C. elegans", "alzheimer\u2019s disease", "ginsenoside rd", "oxidative resistant", "\u03b2-amyloid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36588689", "DateRevised": {"Year": "2023", "Month": "01", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "15"}], "Language": ["eng"], "ELocationID": ["1074397", "10.3389/fphar.2022.1074397"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Ginsenoside Rd protects transgenic <i>Caenorhabditis elegans</i> from \u03b2-amyloid toxicity by activating oxidative resistant.", "Pagination": {"StartPage": "1074397", "MedlinePgn": "1074397"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a serious public health issue but few drugs are currently available for the disease, and these only target the symptoms. It is well established that oxidative stress plays a crucial role in AD, and there is compelling evidence linking oxidative stress to \u03b2-amyloid (A\u03b2). An exciting source of potential new AD therapeutic medication possibilities is medicinal plants. Ginsenoside Rd (GS-Rd) is one of the main bioactive substances in ginseng extracts. In our study, we used a network pharmacology analysis to identify overlapping GS-Rd (therapeutic) and AD (disease)-relevant protein targets, gene ontology (GO) and bio-process annotation, and the KEGG pathway analysis data predicted that GS-Rd impacts multiple targets and pathways, such as the MAPK signal pathway and the JAT-STAT3 signaling pathway. We then assessed the role of GS-Rd in <i>C. elegans</i> and found that GS-Rd prolongs lifespan, improves resistance to heat stress, delays physical paralysis and increases oxidative stress responses. Overall, these results suggest that GS-Rd protects against the toxicity of A\u03b2. The RNA-seq analysis revealed that GS-Rd achieves its effects by regulating gene expressions like <i>daf-16</i> and <i>skn-1</i>, as well as by participating in many AD-related pathways like the MAPK signaling pathway. In addition, in CL4176 worms, GS-Rd decreased reactive oxygen species (ROS) levels and increased SOD activity. Additional research with transgenic worms showed that GS-Rd aided in the movement of DAF-16 from the cytoplasm to the nucleus. Taken together, the results indicate that GS-Rd significantly reduces A\u03b2 aggregation by targeting the MAPK signal pathway, induces nuclear translocation of DAF-16 to activate downstream signaling pathways and increases resistance to oxidative stress in <i>C. elegans</i> to protect against A\u03b2-induced toxicity."], "CopyrightInformation": "Copyright \u00a9 2022 Mi, Fan, Liu, Wu, Wang, Li, Cai, Qiu, Liu and Cao."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China."}], "LastName": "Mi", "ForeName": "Lihan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China."}], "LastName": "Fan", "ForeName": "Meiling", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific Research Department, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China."}], "LastName": "Liu", "ForeName": "Tianjia", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Effective Components of Traditional Chinese Medicine, Changchun, China."}, {"Identifier": [], "Affiliation": "School of Clinical Medical, Changchun University of Chinese Medicine, Changchun, China."}], "LastName": "Wu", "ForeName": "Donglu", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Effective Components of Traditional Chinese Medicine, Changchun, China."}], "LastName": "Wang", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Jilin University, Changchun, China."}], "LastName": "Li", "ForeName": "Fuqiang", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Jilin University, Changchun, China."}], "LastName": "Cai", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Effective Components of Traditional Chinese Medicine, Changchun, China."}], "LastName": "Qiu", "ForeName": "Zhidong", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Effective Components of Traditional Chinese Medicine, Changchun, China."}], "LastName": "Liu", "ForeName": "Da", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Effective Components of Traditional Chinese Medicine, Changchun, China."}, {"Identifier": [], "Affiliation": "School of Clinical Medical, Changchun University of Chinese Medicine, Changchun, China."}], "LastName": "Cao", "ForeName": "Lingling", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared a shared affiliation with the author(s) YC and FL at the time of review."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alvarez J., Alvarez-Illera P., Santo-Domingo J., Fonteriz R. I., Montero M. (2022). Modeling Alzheimer's disease in Caenorhabditis elegans . Biomedicines 10 (2), 288. 10.3390/biomedicines10020288", "ArticleIdList": ["10.3390/biomedicines10020288", "PMC8869312", "35203497"]}, {"Citation": "Area-Gomez E., de Groof A., Bonilla E., Montesinos J., Tanji K., Boldogh I., et al. (2018). A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease. Cell. Death Dis. 9 (3), 335. 10.1038/s41419-017-0215-0", "ArticleIdList": ["10.1038/s41419-017-0215-0", "PMC5832428", "29491396"]}, {"Citation": "Ashton N. J., Sch\u00f6ll M., Heurling K., Gkanatsiou E., Portelius E., H\u00f6glund K., et al. (2018). Update on biomarkers for amyloid pathology in Alzheimer's disease. Biomark. Med. 12 (7), 799\u2013812. 10.2217/bmm-2017-0433", "ArticleIdList": ["10.2217/bmm-2017-0433", "29902934"]}, {"Citation": "Berger S. I., Iyengar R. (2009). Network analyses in systems pharmacology. Bioinformatics 25 (19), 2466\u20132472. 10.1093/bioinformatics/btp465", "ArticleIdList": ["10.1093/bioinformatics/btp465", "PMC2752618", "19648136"]}, {"Citation": "Boza-Serrano A., Yang Y., Paulus A., Deierborg T. (2018). Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer's disease mouse model 5xFAD. Sci. Rep. 8 (1), 1550. 10.1038/s41598-018-19699-y", "ArticleIdList": ["10.1038/s41598-018-19699-y", "PMC5784016", "29367720"]}, {"Citation": "Chin C. H., Chen S. H., Wu H. H., Ho C. W., Ko M. T., Lin C. Y. (2014). cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, S11. 10.1186/1752-0509-8-s4-s11", "ArticleIdList": ["10.1186/1752-0509-8-s4-s11", "PMC4290687", "25521941"]}, {"Citation": "Chintapaludi S. R., Uyar A., Jackson H. M., Acklin C. J., Wang X., Sasner M., et al. (2020). Staging Alzheimer's disease in the brain and retina of B6.APP/PS1 mice by transcriptional profiling. J. Alzheimers Dis. 73 (4), 1421\u20131434. 10.3233/jad-190793", "ArticleIdList": ["10.3233/jad-190793", "PMC9066610", "31929156"]}, {"Citation": "Dostal V., Roberts C. M., Link C. D. (2010). Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of \u03b2-amyloid peptide toxicity. Genetics 186 (3), 857\u2013866. 10.1534/genetics.110.120436", "ArticleIdList": ["10.1534/genetics.110.120436", "PMC2975290", "20805557"]}, {"Citation": "Fang X. X., Sun G. L., Zhou Y., Qiu Y. H., Peng Y. P. (2018). TGF-\u03b21 protection against A\u03b21-42-induced hippocampal neuronal inflammation and apoptosis by T\u03b2R-I. Neuroreport 29 (2), 141\u2013146. 10.1097/wnr.0000000000000940", "ArticleIdList": ["10.1097/wnr.0000000000000940", "29200096"]}, {"Citation": "Giraldo E., Lloret A., Fuchsberger T., Vi\u00f1a J. (2014). A\u03b2 and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: Protective role of vitamin E. Redox Biol. 2, 873\u2013877. 10.1016/j.redox.2014.03.002", "ArticleIdList": ["10.1016/j.redox.2014.03.002", "PMC4099506", "25061569"]}, {"Citation": "Hanlon M. M., Rakovich T., Cunningham C. C., Ansboro S., Veale D. J., Fearon U., et al. (2019). STAT3 mediates the differential effects of oncostatin M and TNF\u03b1 on RA synovial fibroblast and endothelial cell function. Front. Immunol. 10, 2056. 10.3389/fimmu.2019.02056", "ArticleIdList": ["10.3389/fimmu.2019.02056", "PMC6724663", "31555281"]}, {"Citation": "Hardy J. A., Higgins G. A. (1992). Alzheimer's disease: The amyloid cascade hypothesis. Science 256 (5054), 184\u2013185. 10.1126/science.1566067", "ArticleIdList": ["10.1126/science.1566067", "1566067"]}, {"Citation": "Hardy J., Allsop D. (1991). Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12 (10), 383\u2013388. 10.1016/0165-6147(91)90609-v", "ArticleIdList": ["10.1016/0165-6147(91)90609-v", "1763432"]}, {"Citation": "Heneka M. T., O'Banion M. K., Terwel D., Kummer M. P. (2010). Neuroinflammatory processes in Alzheimer's disease. J. Neural Transm. 117 (8), 919\u2013947. 10.1007/s00702-010-0438-z", "ArticleIdList": ["10.1007/s00702-010-0438-z", "20632195"]}, {"Citation": "Hou J., Xue J., Lee M., Sung C. (2017). Ginsenoside Rd as a potential neuroprotective agent prevents trimethyltin injury. Biomed. Rep. 6 (4), 435\u2013440. 10.3892/br.2017.864", "ArticleIdList": ["10.3892/br.2017.864", "PMC5374896", "28413642"]}, {"Citation": "Jastrzebski K., Kacperska M. J., Majos A., Grodzka M., Glabinski A. (2015). Hemorrhagic stroke, cerebral amyloid angiopathy, Down syndrome and the Boston criteria. Neurol. Neurochir. Pol. 49 (3), 193\u2013196. 10.1016/j.pjnns.2015.04.006", "ArticleIdList": ["10.1016/j.pjnns.2015.04.006", "26048609"]}, {"Citation": "Karran E., De Strooper B. (2016). The amyloid cascade hypothesis: Are we poised for success or failure? J. Neurochem. 139, 237\u2013252. 10.1111/jnc.13632", "ArticleIdList": ["10.1111/jnc.13632", "27255958"]}, {"Citation": "Li L., Li T., Tian X., Zhao L. (2021). Ginsenoside rd attenuates tau phosphorylation in olfactory bulb, spinal cord, and telencephalon by regulating glycogen synthase kinase 3\u03b2 and cyclin-dependent kinase 5 Evid. Based. Complement. Altern. Med. 2021, 4485957. 10.1155/2021/4485957", "ArticleIdList": ["10.1155/2021/4485957", "PMC8720614", "34987593"]}, {"Citation": "Li Q., Wang Y., Peng W., Jia Y., Tang J., Li W., et al. (2019). MicroRNA-101a regulates autophagy phenomenon via the MAPK pathway to modulate alzheimer's-associated pathogenesis. Cell. Transpl. 28 (8), 1076\u20131084. 10.1177/0963689719857085", "ArticleIdList": ["10.1177/0963689719857085", "PMC6728707", "31204500"]}, {"Citation": "Li Y., Wang M. L., Zhang B., Fan X. X., Tang Q., Yu X., et al. (2022). Antidepressant-like effect and mechanism of ginsenoside rd on rodent models of depression. Drug Des. devel. Ther. 16, 843\u2013861. 10.2147/DDDT.S351421", "ArticleIdList": ["10.2147/DDDT.S351421", "PMC8974469", "35370402"]}, {"Citation": "Liu J., Yan X., Li L., Li Y., Zhou L., Zhang X., et al. (2015). Ginsenoside rd improves learning and memory ability in APP transgenic mice. J. Mol. Neurosci. 57 (4), 522\u2013528. 10.1007/s12031-015-0632-4", "ArticleIdList": ["10.1007/s12031-015-0632-4", "26358038"]}, {"Citation": "Liu J., Yan X., Li L., Zhu Y., Qin K., Zhou L., et al. (2012). Ginsennoside rd attenuates cognitive dysfunction in a rat model of Alzheimer's disease. Neurochem. Res. 37 (12), 2738\u20132747. 10.1007/s11064-012-0866-2", "ArticleIdList": ["10.1007/s11064-012-0866-2", "22903450"]}, {"Citation": "Pinheiro L., Faustino C. (2019). Therapeutic strategies targeting amyloid-beta in Alzheimer's disease. Curr. Alzheimer Res. 16 (5), 418\u2013452. 10.2174/1567205016666190321163438", "ArticleIdList": ["10.2174/1567205016666190321163438", "30907320"]}, {"Citation": "Reichenbach N., Delekate A., Plescher M., Schmitt F., Krauss S., Blank N., et al. (2019). Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's disease model. EMBO Mol. Med. 11 (2), e9665. 10.15252/emmm.201809665", "ArticleIdList": ["10.15252/emmm.201809665", "PMC6365929", "30617153"]}, {"Citation": "Ren K., Li S., Ding J., Zhao S., Liang S., Cao X., et al. (2021). Ginsenoside Rd attenuates mouse experimental autoimmune neuritis by modulating monocyte subsets conversion. Biomed. Pharmacother. 138, 111489. 10.1016/j.biopha.2021.111489", "ArticleIdList": ["10.1016/j.biopha.2021.111489", "33743332"]}, {"Citation": "Roberts J. A., Varma V. R., An Y., Varma S., Candia J., Fantoni G., et al. (2021). A brain proteomic signature of incipient Alzheimer's disease in young APOE \u03b54 carriers identifies novel drug targets. Sci. Adv. 7 (46), eabi8178. 10.1126/sciadv.abi8178", "ArticleIdList": ["10.1126/sciadv.abi8178", "PMC8580310", "34757788"]}, {"Citation": "Roda A. R., Serra-Mir G., Montoliu-Gaya L., Tiessler L., Villegas S. (2022). Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease. Neural Regen. Res. 17 (8), 1666\u20131674. 10.4103/1673-5374.332127", "ArticleIdList": ["10.4103/1673-5374.332127", "PMC8820696", "35017413"]}, {"Citation": "Rudajev V., Novotny J. (2022). Cholesterol as a key player in amyloid \u03b2-mediated toxicity in Alzheimer's disease. Front. Mol. Neurosci. 15, 937056. 10.3389/fnmol.2022.937056", "ArticleIdList": ["10.3389/fnmol.2022.937056", "PMC9453481", "36090253"]}, {"Citation": "Song D., Jiang X., Liu Y., Sun Y., Cao S., Zhang Z. (2018). Asiaticoside attenuates cell growth inhibition and apoptosis induced by a\u03b2(1-42) via inhibiting the TLR4/NF-\u03baB signaling pathway in human brain microvascular endothelial cells. Front. Pharmacol. 9, 28. 10.3389/fphar.2018.00028", "ArticleIdList": ["10.3389/fphar.2018.00028", "PMC5797575", "29441018"]}, {"Citation": "Tang K., Qin W., Wei R., Jiang Y., Fan L., Wang Z., et al. (2022). Ginsenoside Rd ameliorates high glucose-induced retinal endothelial injury through AMPK-STRT1 interdependence. Pharmacol. Res. 179, 106123. 10.1016/j.phrs.2022.106123", "ArticleIdList": ["10.1016/j.phrs.2022.106123", "35150861"]}, {"Citation": "Tatulian S. A. (2022). Challenges and hopes for Alzheimer's disease. Drug Discov. Today 27 (4), 1027\u20131043. 10.1016/j.drudis.2022.01.016", "ArticleIdList": ["10.1016/j.drudis.2022.01.016", "35121174"]}, {"Citation": "T\u00f3thov\u00e1 Z., \u0160emel\u00e1kov\u00e1 M., Sol\u00e1rov\u00e1 Z., Tomc J., Debeljak N., Sol\u00e1r P. (2021). The role of PI3K/AKT and MAPK signaling pathways in erythropoietin signalization. Int. J. Mol. Sci. 22 (14), 7682. 10.3390/ijms22147682", "ArticleIdList": ["10.3390/ijms22147682", "PMC8307237", "34299300"]}, {"Citation": "Viola K. L., Klein W. L. (2015). Amyloid \u03b2 oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Acta Neuropathol. 129 (2), 183\u2013206. 10.1007/s00401-015-1386-3", "ArticleIdList": ["10.1007/s00401-015-1386-3", "PMC4390393", "25604547"]}, {"Citation": "Wang E., Wang N., Zou Y., Fahim M., Zhou Y., Yang H., et al. (2022). Black mulberry (Morus nigra) fruit extract alleviated AD-Like symptoms induced by toxic A\u03b2 protein in transgenic Caenorhabditis elegans via insulin DAF-16 signaling pathway. Food Res. Int. 160, 111696. 10.1016/j.foodres.2022.111696", "ArticleIdList": ["10.1016/j.foodres.2022.111696", "36076399"]}, {"Citation": "Wang Q., Yang F., Guo W., Zhang J., Xiao L., Li H., et al. (2014). Caenorhabditis elegans in Chinese medicinal studies: Making the case for aging and neurodegeneration. Rejuvenation Res. 17 (2), 205\u2013208. 10.1089/rej.2013.1512", "ArticleIdList": ["10.1089/rej.2013.1512", "PMC3995508", "24125529"]}, {"Citation": "Wang X., Li H., Liu Y., Wu H., Wang H., Jin S., et al. (2020). Velvet antler methanol extracts (MEs) protects against oxidative stress in Caenorhabditis elegans by SKN-1. Biomed. Pharmacother. 121, 109668. 10.1016/j.biopha.2019.109668", "ArticleIdList": ["10.1016/j.biopha.2019.109668", "31766103"]}, {"Citation": "Wang Z. H., Xiang J., Liu X., Yu S. P., Manfredsson F. P., Sandoval I. M., et al. (2019). Deficiency in BDNF/TrkB neurotrophic activity stimulates \u03b4-secretase by upregulating C/EBP\u03b2 in Alzheimer's disease. Cell. Rep. 28 (3), 655\u2013669. e655. 10.1016/j.celrep.2019.06.054", "ArticleIdList": ["10.1016/j.celrep.2019.06.054", "PMC6684282", "31315045"]}, {"Citation": "Yan X., Hu G., Yan W., Chen T., Yang F., Zhang X., et al. (2017). Ginsenoside Rd promotes non-amyloidogenic pathway of amyloid precursor protein processing by regulating phosphorylation of estrogen receptor alpha. Life Sci. 168, 16\u201323. 10.1016/j.lfs.2016.11.002", "ArticleIdList": ["10.1016/j.lfs.2016.11.002", "27825720"]}, {"Citation": "Yang F., Diao X., Wang F., Wang Q., Sun J., Zhou Y., et al. (2020). Identification of key regulatory genes and pathways in prefrontal cortex of Alzheimer's disease. Interdiscip. Sci. 12 (1), 90\u201398. 10.1007/s12539-019-00353-8", "ArticleIdList": ["10.1007/s12539-019-00353-8", "32006383"]}, {"Citation": "Yang L. X., Zhang X., Zhao G. (2016). Ginsenoside rd attenuates DNA damage by increasing expression of DNA glycosylase endonuclease VIII-like proteins after focal cerebral ischemia. Chin. Med. J. 129 (16), 1955\u20131962. 10.4103/0366-6999.187851", "ArticleIdList": ["10.4103/0366-6999.187851", "PMC4989428", "27503022"]}, {"Citation": "Yang S., Lian G. (2020). ROS and diseases: Role in metabolism and energy supply. Mol. Cell. Biochem. 467 (1-2), 1\u201312. 10.1007/s11010-019-03667-9", "ArticleIdList": ["10.1007/s11010-019-03667-9", "PMC7089381", "31813106"]}, {"Citation": "Younus H. (2018). Therapeutic potentials of superoxide dismutase. Int. J. Health Sci. 12 (3), 88\u201393.", "ArticleIdList": ["PMC5969776", "29896077"]}, {"Citation": "Zhang X. G., Wang X., Zhou T. T., Wu X. F., Peng Y., Zhang W. Q., et al. (2016). Scorpion venom heat-resistant peptide protects transgenic Caenorhabditis elegans from beta-amyloid toxicity. Front. Pharmacol. 7, 227. 10.3389/fphar.2016.00227", "ArticleIdList": ["10.3389/fphar.2016.00227", "PMC4960250", "27507947"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "19"}, {"Year": "2022", "Month": "11", "Day": "29"}, {"Year": "2023", "Month": "1", "Day": "2", "Hour": "3", "Minute": "39"}, {"Year": "2023", "Month": "1", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["36588689", "PMC9797510", "10.3389/fphar.2022.1074397", "1074397"]}}], "PubmedBookArticle": []}